Med-Chemist : "Quintessential Medicinal Chemistry"
Friday, September 19, 2014
FDA Approves Movantik (naloxegol) for Opioid-Induced Constipation
In continuation with my update on
Movantik
(naloxegol)
The U.S. Food and Drug Administration today approved
Movantik
(naloxegol), an oral treatment for opioid-induced constipation in adults with chronic non-cancer pain.
FDA Approves Movantik (naloxegol) for Opioid-Induced Constipation
No comments:
Post a Comment
Newer Post
Older Post
Home
View mobile version
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment